• Cancel
    Date：2021-09

    Exclusive Financial Advisor to Xinyi Semi

  • Cancel
    Date：2021-08

    Exclusive Financial Advisor to AffaCare

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=593

    Hangzhou, China, August 27, 2021 - Lynk Pharmaceuticals CO., LTD (hereinafter referred to as “Lynk Pharmaceuticals”), an innovative pharmaceutical R&D company, today announced that it has successfully completed Series B financing of $50 million, with Lilly Asia Ventures (LAV) as lead investor, New Alliance Capital and Hangzhou HEDA Biological Medicine Venture Capital Partnership (L.L.P.) as co-investors, and its original shareholders Legend Capital and Med-Fine Capital as participating investors. The proceeds from this round of financing will mainly be used to conduct Phase I and II clinical trials for multiple programs in the R&D pipeline of Lynk Pharmaceuticals. In addition, the funding will be used to expand international business, strengthen international collaborations with leading companies and support preclinical development of new projects. CEC Capital acted as the exclusive financial advisor to Lynk Pharmaceuticals in this transaction.

  • Cancel
    Date：2021-08

    Exclusive Financial Advisor to Zuoyi Tech

  • Cancel
    Date：2021-08

    Exclusive Financial Advisor to New SORL

  • Cancel
    Date：2021-08

    Exclusive Financial Advisor to WENHEYOU

  • Cancel
    Date：2021-08

    Exclusive Financial Advisor to Berry Oncology

  • Cancel
    Date：2021-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=584

    M Stand, a trendy coffee chain brand, has announced its closing of Series B financing of over RMB500 million. The transaction was co-led by BA Capital and GenBridge Capital, two experienced venture capital investors in China’s consumer sector, and Gaorong Capital followed. Existing investors including CMC Capital Group and Challenjers Capital also participated. CEC Capital Group served as the lead financial advisor in this round. The transaction was the largest Series B financing in China’s heated coffee sector. Earlier this year, M Stand caught investors’ attention when it announced its closing of Series A financing led by CMC Capital Group and Challenjers Capital. Since then the company has vigorously built a market image of "better coffee enjoyed in trendier space” with its chic store designs and has aggressively pursued geographical expansion, nearly tripling its store counts in the past 6 months. With over thirty stores already opened in Shanghai, Hangzhou, Ningbo, Shenzhen and Guangzhou, M Stand will continue to speed up new store openings with a target of crossing the 100 store threshold by the end of the year.

  • Cancel
    Date：2021-07

    CEC Capital Served as Financial Advisor